Peter Reinhart
Founding Director, Institute for Applied Life Sciences · University of Massachusetts Amherst
Peter Reinhart is founding director of the Institute for Applied LIfe Sciences which turns research into innovative products and services
Applied LIfe Sciences Biotechnology Drug Discovery Programs Drug Development Orphan Disease
Deborah Kurrasch
Associate Professor, Department of Medical Genetics · University of Calgary
Kurrasch’s research is focused on genetic programs that govern hypothalamic development using both mice and zebrafish as model organisms.
Molecular Biology Developmental Biology Pharmacology Neuroscience Genetics
Susan Desaulniers
Senior Director, Cardiovascular & Metabolism · Biogen
Susan Desaulniers is an expert in developing leading global clinical programs that protect people from infectious diseases.
Drug Discovery Regulatory Compliance Global Pharmaceutical and Clinical Development Programs Project Management Quality Assurance
Ron Priefer
Professor/Entrepreneur · MCPHS / New England Breath
Ron Priefer is an expert in NMR spectroscopy, materials science, liquid chromatography-mass spectrometry, research design, and Polymers.
Academic Advising Mass Spectrometry Organic Synthesis Research Organic Chemistry
Thomas D. Roper, Ph.D.
Director, Pharmaceutical Engineering| Engineering Foundation Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering
Dr. Roper specializes in efforts to bring engineering and science closer to patients who utilize medicines via novel technologies.
Metabolic Engineering and Biocatalysis 3D Printing of Dose Forms Long Acting Therapy Development Nanomaterials and Particle Sciences Continuous Chemical Reaction Engineering
Siobhan Malany
Associate Professor · University of Florida
Siobhan Malany studies the effects of microgravity on human muscle biology using an automated tissue chip system.
Space Age-related Msucle Atrophy Drug Discovery and Screening Space Medicine Human Muscle Biology
Dr. Raphael (Rafi) Hofstein
President & CEO · MaRS Innovation
Turning academic ideas into commercial realities
Corporate & Business Strategy Early-Stage Investing Life Sciences and Healthcare Technology Transfer Commercialization of Innovation
John McCulloch
Founder & Managing Director · Burloch Group Inc.
Engaging and knowledgeable speaker with deep expertise in biotechnology investment.
Biotechnology Pharmaceuticals Innovation Investment
B. Frank Gupton, Ph.D.
Floyd D. Gottwald, Jr. Chair in Pharmaceutical Engineering; Chair, Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering
Professor Gupton's research is focused on the development of new technologies that will streamline organic synthesis
Cross-Coupling Catalysis Flow Chemistry / Continual Chemical Processing Organic Synthesis in Pharmaceutical Applications
Daniele Piomelli
Distinguished Professor · UC Irvine
Daniele Piomelli's research is focused on the function of lipid-derived messengers, with particular emphasis on endogenous cannabinoids.
Anatomy & Neurobiology Cellular Pharmacology CBD Marijuana Neuropharmacology
Sandra K. Weller, Ph.D.
Professor and Chair, Department of Molecular Biology and Biophysics · University of Connecticut
Sandra K. Weller, Ph.D., is an expert in the herpes simplex virus.
Biochemistry Biophysics Molecular Biology Herpes Simplex Virus
Bin Chen
Assistant Professor of Pediatrics and Human Development · Michigan State University
Dr. Chen is the founding member of DahShu, a non-profit organization to promote research and education in data sciences.
Cancer Therapy Drug Repositioning Translational Bioinformatics AI Big Data
Douglas Scharre
Professor of Clinical Neurology and Psychiatry | College of Medicine · The Ohio State University
Dr. Scharre specializes in cognitive disorders and dementias, including Alzheimer's disease
Neurology Neurobehavioral Manifestations Lewy Body Disease Dementia, Multi-Infarct Amnesia, Transient Global
Dr Jonathan A. G. Cox
Lecturer in Microbiology · Aston University
Dr Cox's research interests surround the discovery of new antibiotics & identifying the mechanisms by which those antibiotics kill bacteria.
Health Sciences Biochemistry Antibiotics Antimicrobial Resistance Micro-Organisms
Andrew Lover
Associate Professor of Epidemiology and Deputy Director, New England Center of Excellence in Vector-Borne Disease · University of Massachusetts Amherst
Andrew Lover is an infectious disease epidemiologist whose work focuses on malaria and other vector-borne diseases.
Tick-borne Diseases Infectious Disease Vector-Borne Diseases Drug Development Malaria
Emily Walsh
Principal Consultant · Halloran Consulting Group, Inc.
Recovering Scientist
Personalized Medicine and Genetics Translational Medicine Transitioning From the Bench Project Management 101 Program Management 101
Adrian Newman-Tancredi
Neuropharmacology Consulting · NeuroAct Communication
Experienced public speaker and neuropharmacologist with proven expertise in study of antipsychotics, antidepressants and analgesics.
Antipsychotics Neuropharmacology Serotonin Depression
Zubair Karim, PhD
Assistant Professor, Department of Interdisciplinary Health Sciences · Augusta University
Karim researches signaling and the SNARE secretory machinery in platelets to understand their contribution to health and disease.
Smoking and Cardiovascular Disease Thrombosis Hemostasis Platelet Exocytosis and Signaling E-cigarettes
Jacob Elmer, PhD
Dicciani Endowed Professor of Chemical and Biological Engineering | College of Engineering · Villanova University
Jacob Elmer, PhD, is an expert in genetic engineering, GMOs, and gene therapy
CAR-T Cell Therapy CRISPR-Cas9 Hemoglobin Immunotherapy GMOs
Jessica Fortin
Assistant Professor of Pathobiology and Diagnostic Investigation · Michigan State University
Dr. Jessica S. Fortin is a board-certified veterinary anatomic pathologist and holds both chemistry and pharmacy licenses from Quebec.
Toxicology Molecular Pharmacology Pharmacy Medicinal Chemistry Pathology